Case report: Pentamidine and polymorphic ventricular tachycardia revisited

Sridhar Mani, A. G. Kocheril, V. T. Andriole

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Pentamidine isethionate has been associated with ventricular tachyarrhythmias, including torsade de pointes. This article reports two cases of this complication and reviews all reported cases to date. Pentamidine-induced torsade de pointes may be related to serum magnesium levels and hypomagnesemia may synergistically induce torsade. Torsade de pointes occurred after an average of 10 days of treatment with pentamidine. In these patients, no other acute side effects of pentamidine were observed. Torsade de pointes can be treated when recognized early, possibly without discontinuation of pentamidine. When QTc interval prolongation is observed, early magnesium supplementation is advocated.

Original languageEnglish (US)
Pages (from-to)236-240
Number of pages5
JournalAmerican Journal of the Medical Sciences
Volume305
Issue number4
StatePublished - 1993
Externally publishedYes

Fingerprint

Pentamidine
Ventricular Tachycardia
Torsades de Pointes
Magnesium
Tachycardia
Serum

Keywords

  • Acquired immune deficiency syndrome
  • Magnesium
  • Pentamidine
  • Torsade de pointes
  • Ventricular arrhythmia

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Case report : Pentamidine and polymorphic ventricular tachycardia revisited. / Mani, Sridhar; Kocheril, A. G.; Andriole, V. T.

In: American Journal of the Medical Sciences, Vol. 305, No. 4, 1993, p. 236-240.

Research output: Contribution to journalArticle

@article{56af2fbcc8684da7ab78d0b554cd7a1d,
title = "Case report: Pentamidine and polymorphic ventricular tachycardia revisited",
abstract = "Pentamidine isethionate has been associated with ventricular tachyarrhythmias, including torsade de pointes. This article reports two cases of this complication and reviews all reported cases to date. Pentamidine-induced torsade de pointes may be related to serum magnesium levels and hypomagnesemia may synergistically induce torsade. Torsade de pointes occurred after an average of 10 days of treatment with pentamidine. In these patients, no other acute side effects of pentamidine were observed. Torsade de pointes can be treated when recognized early, possibly without discontinuation of pentamidine. When QTc interval prolongation is observed, early magnesium supplementation is advocated.",
keywords = "Acquired immune deficiency syndrome, Magnesium, Pentamidine, Torsade de pointes, Ventricular arrhythmia",
author = "Sridhar Mani and Kocheril, {A. G.} and Andriole, {V. T.}",
year = "1993",
language = "English (US)",
volume = "305",
pages = "236--240",
journal = "American Journal of the Medical Sciences",
issn = "0002-9629",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Case report

T2 - Pentamidine and polymorphic ventricular tachycardia revisited

AU - Mani, Sridhar

AU - Kocheril, A. G.

AU - Andriole, V. T.

PY - 1993

Y1 - 1993

N2 - Pentamidine isethionate has been associated with ventricular tachyarrhythmias, including torsade de pointes. This article reports two cases of this complication and reviews all reported cases to date. Pentamidine-induced torsade de pointes may be related to serum magnesium levels and hypomagnesemia may synergistically induce torsade. Torsade de pointes occurred after an average of 10 days of treatment with pentamidine. In these patients, no other acute side effects of pentamidine were observed. Torsade de pointes can be treated when recognized early, possibly without discontinuation of pentamidine. When QTc interval prolongation is observed, early magnesium supplementation is advocated.

AB - Pentamidine isethionate has been associated with ventricular tachyarrhythmias, including torsade de pointes. This article reports two cases of this complication and reviews all reported cases to date. Pentamidine-induced torsade de pointes may be related to serum magnesium levels and hypomagnesemia may synergistically induce torsade. Torsade de pointes occurred after an average of 10 days of treatment with pentamidine. In these patients, no other acute side effects of pentamidine were observed. Torsade de pointes can be treated when recognized early, possibly without discontinuation of pentamidine. When QTc interval prolongation is observed, early magnesium supplementation is advocated.

KW - Acquired immune deficiency syndrome

KW - Magnesium

KW - Pentamidine

KW - Torsade de pointes

KW - Ventricular arrhythmia

UR - http://www.scopus.com/inward/record.url?scp=0027153434&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027153434&partnerID=8YFLogxK

M3 - Article

C2 - 8475949

AN - SCOPUS:0027153434

VL - 305

SP - 236

EP - 240

JO - American Journal of the Medical Sciences

JF - American Journal of the Medical Sciences

SN - 0002-9629

IS - 4

ER -